Cadrenal Therapeutics, Common Stock Technical Analysis

CVKD Stock   14.15  0.44  3.21%   
As of the 28th of November, Cadrenal Therapeutics, shows the mean deviation of 6.09, and Risk Adjusted Performance of 0.1216. Cadrenal Therapeutics, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cadrenal Therapeutics, downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Cadrenal Therapeutics, is priced correctly, providing market reflects its regular price of 14.15 per share. Given that Cadrenal Therapeutics, has jensen alpha of 0.9537, we suggest you to validate Cadrenal Therapeutics, Common's prevailing market performance to make sure the company can sustain itself at a future point.

Cadrenal Therapeutics, Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cadrenal, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cadrenal
  
Cadrenal Therapeutics,'s Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Cadrenal Therapeutics, Analyst Consensus

Target PriceAdvice# of Analysts
3.0Strong Buy2Odds
Cadrenal Therapeutics, Common current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cadrenal analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cadrenal stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cadrenal Therapeutics,, talking to its executives and customers, or listening to Cadrenal conference calls.
Cadrenal Analyst Advice Details
Cadrenal Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cadrenal Therapeutics, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cadrenal Therapeutics, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cadrenal Therapeutics, Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cadrenal Therapeutics, volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Cadrenal Therapeutics, Trend Analysis

Use this graph to draw trend lines for Cadrenal Therapeutics, Common. You can use it to identify possible trend reversals for Cadrenal Therapeutics, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cadrenal Therapeutics, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cadrenal Therapeutics, Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cadrenal Therapeutics, Common applied against its price change over selected period. The best fit line has a slop of   0.12  , which means Cadrenal Therapeutics, Common will continue generating value for investors. It has 122 observation points and a regression sum of squares at 503.44, which is the sum of squared deviations for the predicted Cadrenal Therapeutics, price change compared to its average price change.

About Cadrenal Therapeutics, Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cadrenal Therapeutics, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cadrenal Therapeutics, Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cadrenal Therapeutics, price pattern first instead of the macroeconomic environment surrounding Cadrenal Therapeutics,. By analyzing Cadrenal Therapeutics,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cadrenal Therapeutics,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cadrenal Therapeutics, specific price patterns or momentum indicators. Please read more on our technical analysis page.

Cadrenal Therapeutics, November 28, 2024 Technical Indicators

Most technical analysis of Cadrenal help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cadrenal from various momentum indicators to cycle indicators. When you analyze Cadrenal charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Cadrenal Stock analysis

When running Cadrenal Therapeutics,'s price analysis, check to measure Cadrenal Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cadrenal Therapeutics, is operating at the current time. Most of Cadrenal Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Cadrenal Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cadrenal Therapeutics,'s price. Additionally, you may evaluate how the addition of Cadrenal Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites